[{"id":"cctg","kind":"institution","name":"Canadian Cancer Trials Group (CCTG)","route":"/institutions/cctg/","commit":"0bdbdae6c6","date":"2026-09-09","author":"Jude Gomila","message":"Editing pass: every TL;DR and summary stands alone","file":"src/data/groups.ts","type":"changed","fields":[{"field":"summary","before":"\"Based at Queen's University. CHALLENGE (CO.21, NEJM 2025) showed a structured exercise programme improves survival in colon cancer; MA.17 (extended letrozole) and PA.3 (erlotinib in pancreatic cancer) were earlier la...","after":"\"CCTG is based at Queen's University. CHALLENGE (CO.21, NEJM 2025) showed a structured exercise programme improves survival in colon cancer; MA.17 (extended letrozole) and PA.3 (erlotinib in pancreatic cancer) were ea..."}]},{"id":"cctg","kind":"institution","name":"Canadian Cancer Trials Group (CCTG)","route":"/institutions/cctg/","commit":"7febd29686","date":"2026-09-06","author":"Jude Gomila","message":"Institutions & community cluster: OpenAlex output ranking, trial leadership index, cooperative groups, funding flows, gaps/bounties, changel","file":"src/data/groups.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"city"},{"field":"country"},{"field":"lat"},{"field":"lng"},{"field":"website"},{"field":"tldr"},{"field":"summary"},{"field":"programs"},{"field":"technologies"},{"field":"cancers"}]}]